Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;27(10):4011-4022.
doi: 10.1007/s00520-019-04892-0. Epub 2019 Jul 8.

Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines

Joanne M Bowen #  1 , Rachel J Gibson #  2 , Janet K Coller  3 , Nicole Blijlevens  4 , Paolo Bossi  5 , Noor Al-Dasooqi  3 , Emma H Bateman  3 , Karen Chiang  6 , Charlotte de Mooij  4 , Bronwen Mayo  2 , Andrea M Stringer  2 , Wim Tissing  7 , Hannah R Wardill  3 , Ysabella Z A van Sebille  2 , Vinisha Ranna  8 , Anusha Vaddi  9 , Dorothy Mk Keefe  3 , Rajesh V Lalla  10 , Karis Kin Fong Cheng  11 , Sharon Elad  9 ; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
Affiliations

Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines

Joanne M Bowen et al. Support Care Cancer. 2019 Oct.

Abstract

Purpose: The aim of this study was to update the clinical practice guidelines for the use of agents for the prevention and/or treatment of gastrointestinal mucositis (GIM).

Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, and No Guideline Possible.

Results: A total of 78 papers across 13 interventions were examined of which 25 were included in the final review. No new guidelines were possible for any agent due to inadequate and/or conflicting evidence. Existing guidelines for probiotics and hyperbaric oxygen were unchanged.

Conclusions: Of the agents studied for the prevention and treatment of GIM, the evidence continues to support use of probiotics containing Lactobacillus spp. for prevention of chemoradiotherapy and radiotherapy-induced diarrhea in patients with pelvic malignancy, and hyperbaric oxygen therapy to treat radiation-induced proctitis. Additional well-designed research is encouraged to enable a decision regarding palifermin, glutamine, sodium butyrate, and dietary interventions, for the prevention or treatment of GIM.

Keywords: Clinical management; Gastrointestinal; Guidelines; Mucositis.

PubMed Disclaimer

References

    1. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB, Mucositis Study Section of the MASCC and the ISOO (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025 - DOI - PubMed
    1. Carlotto A, Hogsett VL, Mairorini EM, Razulis JG, Sonis ST (2013) The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics 31:753–766 - DOI - PubMed
    1. Gibson RJ, Cummins AG, Bowen JM, Logan RM, Healey T, Keefe DMK (2006) Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asia Pac J Clin Oncol 2:39–49 - DOI
    1. Blijlevens NM, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269–1278 - DOI - PubMed
    1. Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radazum M, Logan RM, Mayo B, Keefe DMK, Gibson RJ (2013) Biomarkers of chemotherapy-induced diarrhea: a clinical study of intestinal microbiome alterations, intestinal inflammation and circulating matrix metalloproteinases. Support Care Cancer 21:1843–1852 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources